POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24h (2.28.2021, 10:30am CET, WHO):   U.S. 72,812    India 16,752    Brazil 65,169    Russia 11,534    The United Kingdom 8,523    France 24,537    Italy 20,488    Turkey 9,205    Germany 9,762    Columbia 3,567    Argentina 5,469    Mexico 7,512    Poland 12,097    Iran 7,975    South Africa 1,654    Ukraine 8,172    Indonesia 6,208    Peru 7,641    Czechia 14,815    The Netherlands 5,151    Canada 3,255    Chile 4,589    Portugal 1,027    Romania 3,761    Iraq 3,543    Sweden 4,811    Pakistan 1,315    Philippines 2,920    Serbia 3,339    Austria 2,060    Japan 1,201    Hungary 4,948    United Arab Emirates 3,434    Jordan 2,584    Lebanon 3,100    Slovakia 2,848    Malaysia 2,364    Belarus 1,602    Ecuador 1,430    Bolivia 1,069    Bulgaria 1,681    Palestine 1,623    Greece 1,732    Moldova 1,452    Paraguay 1,414    Estonia 1,569    China 42    Singapore 12    New Zealand 0    Australia 7    South Korea 356   

U.S. sluggish in testing Wuhan coronavirus, says Science

Christian Fernsby |
The United States bungled its coronavirus testing as it has been slow in an attempt to develop reliable diagnostic tests and use them widely, the journal Science reported.

Article continues below



Topics: U.S.    WUHAN    CORONAVIRUS   

The U. S. Centers for Disease Control and Prevention (CDC) has done only 459 tests by the end of February, according to the journal.

It was partially because the CDC initially set strict criteria for novel coronavirus testing, which limited the availability to people who had returned from an affected country or had been known to be in contact with someone with the virus. After it changed the criteria by the end of February, the confirmed cases in the country kept increasing.

In addition, part of CDC's testing kits went awry. Although it developed the RT-PCR tools in early February, it turned out that some of them contained a faulty reagent, thus producing inconclusive results and further slowing down the testing efforts of local health departments.

"There have been blunders, and there could be an underlying catastrophe that we don't know about," said epidemiologist Michael Mina, who helps run a microbiology testing lab at Brigham and Women's Hospital.

Labs like Mina's were not allowed to test novel coronavirus without approval until U.S. Food and Drug Administration loosened the limits on Feb. 29.

When the United States declared the outbreak a public health emergency on Jan. 31, a bureaucratic process kicked in that requires FDA's "emergency use approval" for any tests, according to Science.

"The declaration of a public health emergency did exactly what it shouldn't have. It limited the diagnostic capacity of this country," Mina says. "It's insane."

"If we had the ability to test earlier, I'm sure we would have identified patients earlier," said Jeffrey Duchin, health officer for Seattle and King County in Washington State.

Washington state announced on Monday four more people died from the coronavirus, bringing the number of deaths in the country to six, all in Washington.

Over 100 Wuhan coronavirus cases have been confirmed so far in the United States.


What to read next

CDC raises Wuhan coronavirus travel alert, Hebei confirms first death outside epicentre
2019-nCoV, extremely dangerous type of coronavirus that spreads fast
Three drugs fairly effective on Wuhan coronavirus on cellular level